Will Roche Holdings AG Basel ADR Common Stock (RHHBY) Lag the Rest of the Stocks in the Healthcare Sector?

The 19 rating InvestorsObserver gives to Roche Holdings AG Basel ADR Common Stock (RHHBY) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 12 percent of stocks in the Healthcare sector, RHHBY’s 19 overall rating means the stock scores better than 19 of all stocks.

RHHBY has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on RHHBY!

See Full RHHBY Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Roche Holdings AG Basel ADR Common Stock Stock Today?

Roche Holdings AG Basel ADR Common Stock (RHHBY) stock has gained 0.13% while the S&P 500 is down -0.12% as of 11:40 AM on Thursday, Nov 30. RHHBY is up $0.04 from the previous closing price of $33.81 on volume of 529,908 shares. Over the past year the S&P 500 is higher by 11.39% while RHHBY is down -17.28%. RHHBY earned $1.96 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.26. Click Here to get the full Stock Report for Roche Holdings AG Basel ADR Common Stock stock.